1. Home
  2. CENN vs CRIS Comparison

CENN vs CRIS Comparison

Compare CENN & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cenntro Electric Group Limited

CENN

Cenntro Electric Group Limited

HOLD

Current Price

$0.15

Market Cap

16.4M

ML Signal

HOLD

Logo Curis Inc.

CRIS

Curis Inc.

HOLD

Current Price

$1.21

Market Cap

14.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENN
CRIS
Founded
2013
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.4M
14.6M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
CENN
CRIS
Price
$0.15
$1.21
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.50
AVG Volume (30 Days)
2.9M
114.9K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,529,541.00
$11,650,000.00
Revenue This Year
N/A
$6.13
Revenue Next Year
N/A
$8.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.56
52 Week Low
$0.13
$1.02
52 Week High
$1.33
$4.50

Technical Indicators

Market Signals
Indicator
CENN
CRIS
Relative Strength Index (RSI) 37.58 42.50
Support Level $0.16 $1.29
Resistance Level $0.18 $1.41
Average True Range (ATR) 0.02 0.12
MACD 0.01 0.00
Stochastic Oscillator 13.52 32.24

Price Performance

Historical Comparison
CENN
CRIS

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: